A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia. (July 2022)

Record Type:: Journal Article
Title:: A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia. (July 2022)
Main Title:: A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia
Authors:: Jankovic, Joseph
Comella, Cynthia
Hauser, Robert A.
Patel, Atul T.
Gross, Todd M.
Rubio, Roman G.
Vitarella, Domenico
Abstract:
Is Part Of:: Toxicon. Volume 214(2022)Supplement 1
Journal:: Toxicon
Issue:: Volume 214(2022)Supplement 1
Issue Display:: Volume 214, Issue 1 (2022)
Year:: 2022
Volume:: 214
Issue:: 1
Issue Sort Value:: 2022-0214-0001-0000
Page Start:: S27
Page End:
Publication Date:: 2022-07
Subjects:: Toxins -- Periodicals
Venom -- Periodicals
615.9
Journal URLs:: http://www.sciencedirect.com/science/journal/00410101 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.toxicon.2021.11.066 ↗
Languages:: English
ISSNs:: 0041-0101
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 8873.050000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 22758.xml